rs267606821
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The ENST00000366971.9(FLVCR1):āc.574T>Cā(p.Cys192Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000105 in 1,612,070 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (ā ā ).
Frequency
Genomes: š 0.000026 ( 0 hom., cov: 32)
Exomes š: 0.0000089 ( 0 hom. )
Consequence
FLVCR1
ENST00000366971.9 missense
ENST00000366971.9 missense
Scores
8
10
1
Clinical Significance
Conservation
PhyloP100: 1.92
Genes affected
FLVCR1 (HGNC:24682): (FLVCR choline and heme transporter 1) This gene encodes a member of the major facilitator superfamily of transporter proteins. The encoded protein is a heme transporter that may play a critical role in erythropoiesis by protecting developing erythroid cells from heme toxicity. This gene may play a role in posterior column ataxia with retinitis pigmentosa and the hematological disorder Diamond-Blackfan syndrome. [provided by RefSeq, Jan 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 14 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.962
PP5
Variant 1-212859026-T-C is Pathogenic according to our data. Variant chr1-212859026-T-C is described in ClinVar as [Likely_pathogenic]. Clinvar id is 18420.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FLVCR1 | NM_014053.4 | c.574T>C | p.Cys192Arg | missense_variant | 1/10 | ENST00000366971.9 | NP_054772.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FLVCR1 | ENST00000366971.9 | c.574T>C | p.Cys192Arg | missense_variant | 1/10 | 1 | NM_014053.4 | ENSP00000355938 | P1 | |
FLVCR1 | ENST00000419102.1 | c.112T>C | p.Cys38Arg | missense_variant | 1/9 | 5 | ENSP00000414680 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152118Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
4
AN:
152118
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000200 AC: 5AN: 250562Hom.: 0 AF XY: 0.00000738 AC XY: 1AN XY: 135466
GnomAD3 exomes
AF:
AC:
5
AN:
250562
Hom.:
AF XY:
AC XY:
1
AN XY:
135466
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000890 AC: 13AN: 1459952Hom.: 0 Cov.: 62 AF XY: 0.00 AC XY: 0AN XY: 725896
GnomAD4 exome
AF:
AC:
13
AN:
1459952
Hom.:
Cov.:
62
AF XY:
AC XY:
0
AN XY:
725896
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152118Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74312
GnomAD4 genome
AF:
AC:
4
AN:
152118
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
74312
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
1
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Posterior column ataxia-retinitis pigmentosa syndrome Pathogenic:4
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jun 07, 2023 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 12, 2010 | - - |
Likely pathogenic, criteria provided, single submitter | research | Ocular Genomics Institute, Massachusetts Eye and Ear | Apr 08, 2021 | The FLVCR1 c.574T>C variant was identified in an individual with retinitis pigmentosa with a presumed recessive inheritance pattern. Through a review of available evidence we were able to apply the following criteria: PM2, PM3, PP1-S. Based on this evidence we have classified this variant as Likely Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 25, 2022 | Variant summary: FLVCR1 c.574T>C (p.Cys192Arg) results in a non-conservative amino acid change located in the Major facilitator superfamily domain (IPR020846) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 2e-05 in 250562 control chromosomes (gnomAD). c.574T>C has been reported in the literature as a biallelic genotype in individuals affected with Posterior Column Ataxia-Retinitis Pigmentosa Syndrome (Rajadhyaksha_2010, Chiabrando_2016). These data indicate that the variant is likely to be associated with disease. At least one publication reports in vitro experimental evidence evaluating an impact on protein function: the variant protein failed to traffick to the plasma membrane and cells expressing the variant had reduced heme-exporting capability, resulting in increased susceptibility to heme-toxicity (Yanatori_2012). One ClinVar submitter has assessed the variant since 2014: the variant was classified as likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Nov 16, 2023 | Published functional studies demonstrate the C192R variant reduced ability to export heme, increased heme toxicity, and reduced half life compared to wild type indicating instability of the C192R protein (PMID: 22483575); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 21267618, 28766925, 24628582, 23506900, 24782769, 27923065, 21070897, 29192808, 31964843, 32466579, 37469134, 36917984, 37808796, 22483575, Ha2023[preprint]) - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 16, 2022 | For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects FLVCR1 function (PMID: 22483575). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt FLVCR1 protein function. ClinVar contains an entry for this variant (Variation ID: 18420). This missense change has been observed in individual(s) with FLVCR1-related conditions (PMID: 21070897, 27923065; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is present in population databases (rs267606821, gnomAD 0.003%). This sequence change replaces cysteine, which is neutral and slightly polar, with arginine, which is basic and polar, at codon 192 of the FLVCR1 protein (p.Cys192Arg). - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 08, 2022 | The c.574T>C (p.C192R) alteration is located in exon 1 (coding exon 1) of the FLVCR1 gene. This alteration results from a T to C substitution at nucleotide position 574, causing the cysteine (C) at amino acid position 192 to be replaced by an arginine (R). Based on data from gnomAD, the C allele has an overall frequency of <0.01% (5/250562) total alleles studied. The highest observed frequency was <0.01% (4/113176) of European (non-Finnish) alleles. This alteration has been detected in the homozygous state and as compound heterozygous in trans with another pathogenic FLVCR1 alteration in unrelated individuals with FLVCR1-related hereditary sensory and autonomic neuropathy (Rajadhyaksha ,2010; Chiabrando, 2016). In addition, this alteration has been found to segregate with FLVCR1-related hereditary sensory and autonomic neuropathy among multiple individuals in one family (Rajadhyaksha, 2010). This amino acid position is not well conserved in available vertebrate species. FLVCR1 p.C192R lacked heme export activity, elicited cellular damage by accumulated heme and was significantly more sensitive to heme toxicity compared to wild-type (Yanatori, 2012). This alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, this alteration is classified as pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
D
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D
MetaSVM
Pathogenic
D
MutationAssessor
Uncertain
M
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D
REVEL
Pathogenic
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
D
Vest4
MutPred
Loss of methylation at K191 (P = 0.0189);
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at